HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Dyslexia (Alexia)

A cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual's chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. (From DSM-IV)
Also Known As:
Alexia; Reading Disorder; Developmental Dyslexia; Alexias; Developmental Reading Disability; Reading Disorder, Developmental; Developmental Reading Disorder; Word Blindness; Blindness, Word; Blindnesses, Word; Developmental Dyslexias; Developmental Reading Disabilities; Developmental Reading Disorders; Disabilities, Developmental Reading; Disability, Developmental Reading; Disorder, Developmental Reading; Disorder, Reading; Disorders, Developmental Reading; Disorders, Reading; Dyslexias; Dyslexias, Developmental; Reading Disabilities, Developmental; Reading Disorders; Reading Disorders, Developmental; Word Blindnesses; Dyslexia, Developmental; Reading Disability, Developmental
Networked: 335 relevant articles (7 outcomes, 64 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
2. Agraphia (Dysgraphia)
3. Learning Disorders (Learning Disability)
4. Aphasia (Dysphasia)
5. Dyslexia (Alexia)

Experts

1. Kere, Juha: 9 articles (11/2015 - 09/2003)
2. Lyytinen, Heikki: 7 articles (07/2015 - 01/2003)
3. Matsson, Hans: 5 articles (11/2015 - 03/2007)
4. Kiese-Himmel, C: 5 articles (03/2011 - 07/2009)
5. Monaco, Anthony P: 5 articles (12/2010 - 03/2008)
6. Richardson, A J: 5 articles (08/2007 - 07/2000)
7. Peyrard-Janvid, Myriam: 4 articles (11/2015 - 03/2007)
8. Nopola-Hemmi, Jaana: 4 articles (07/2015 - 09/2003)
9. Nöthen, Markus M: 4 articles (07/2015 - 03/2007)
10. Valdois, Sylviane: 4 articles (01/2013 - 12/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Dyslexia:
1. atomoxetine (Strattera)FDA LinkGeneric
11/01/2013 - "The atomoxetine-treated dyslexia-only subjects significantly improved from baseline to week 32 on ADHDRS-IV-Parent:Inv Inattentive subscale, K-SCT Parent and Teacher subscales, and WMTB-C Phonological Loop and Central Executive component scores. "
11/01/2013 - "At week 16, atomoxetine treatment resulted in significant (p<0.05) improvement from baseline in subjects with ADHD+D versus placebo on ADHDRS-IV-Parent:Inv Total (primary outcome) and subscales, ADHDRS-IV-Teacher-Version Inattentive subscale, K-SCT Interview Parent and Teacher subscales, and WMTB-C Central Executive component scores; in subjects with Dyslexia-only, atomoxetine versus placebo significantly improved K-SCT Youth subscale scores from baseline. "
01/01/2009 - "Though limited by small sample size, group differences in relation to the comparable changes in improvement in ADHD symptoms could suggest that brain systems related to the therapeutic benefit of atomoxetine in reducing ADHD symptoms may be different in individuals with ADHD+D and ADHD without dyslexia. "
11/01/2013 - "Atomoxetine treatment improved ADHD symptoms in subjects with ADHD+D and ADHD-only, but not in subjects with dyslexia-only without ADHD. "
11/01/2013 - "Children and adolescents (10-16 years of age) with ADHD+D (n=124), dyslexia-only (n=58), or ADHD-only (n=27) received atomoxetine (1.0-1.4 mg/kg/day) or placebo (ADHD-only subjects received atomoxetine) in a 16 week, acute, randomized, double-blind trial with a 16 week, open-label extension phase (atomoxetine treatment only). "
2. Efamol (evening primrose oil)IBA
3. Anticonvulsants (Antiepileptic Drugs)IBA
4. Temazepam (Nocturne)FDA LinkGeneric
5. Carbon MonoxideIBA
6. pamidronate (APD)FDA LinkGeneric
7. Piracetam (Nootropil)IBA
8. Protons (Proton)IBA
9. dicarboxydine (DCD)IBA
10. Silver Sulfadiazine (SSD)FDA LinkGeneric

Therapies and Procedures

1. Lenses
2. Aftercare (After-Treatment)
3. Sign Language
4. Language Therapy (Language Training)
5. Electrodes (Electrode)